Evidence map›Paper›PMID 36749489›Full record

ReviewMedical oncology (Northwood, London, England)2023

Photodynamic therapy in oral cancer: a review of clinical studies.

Seyed Ali Mosaddad, Reza Abdollahi Namanloo, Seyedeh Sara Aghili, Poorya Maskani, Mostafa Alam, Kamyar Abbasi, Farzad Nouri, Elahe Tahmasebi, Mohsen Yazdanian, Hamid Tebyaniyan

Abstract readReview
PubMed Publisher
In one paragraph

Review in Medical oncology (Northwood, London, England), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
20.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 78 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 3 countries.

Seyed Ali MosaddadStudent Research Committee, School of Dentistry, Shiraz University of Medical Sciences, Shiraz, Iran.
Reza Abdollahi NamanlooDentistry Department, Bogomolets National Medical University, Kiev, Ukraine.
Seyedeh Sara AghiliStudent Research Committee, School of Dentistry, Shiraz University of Medical Sciences, Shiraz, Iran.
Poorya MaskaniDental Research Center, Research Institute of Dental Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Mostafa AlamDepartment of Oral and Maxillofacial Surgery, School of Dentistry, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Kamyar AbbasiDepartment of Prosthodontics, School of Dentistry, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Farzad NouriDepartment of Oral and Maxillofacial Surgery, School of Dentistry, Zahedan University of Medical Sciences, Zahedan, Iran.
Elahe TahmasebiResearch Center for Prevention of Oral and Dental Diseases, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Mohsen YazdanianResearch Center for Prevention of Oral and Dental Diseases, Baqiyatallah University of Medical Sciences, Tehran, Iran. myazdaniandr@gmail.com.
Hamid TebyaniyanDepartment of Science and Research, Islimic Azade University, Tehran, Iran. tebyan.hamid@yahoo.com.ORCID http://orcid.org/0000-0002-5647-637X
Shahid Beheshti University of Medical Sciences · IRBaqiyatallah University of Medical Sciences · IRShiraz University of Medical Sciences · IRBogomolets National Medical University · UAIslamic Azad University, Science and Research Branch · IRZahedan University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A significant mortality rate is associated with oral cancer, particularly in cases of late-stage diagnosis. Since the last decades, oral cancer survival rates have only gradually improved despite advances in treatment. This poor success rate is mainly due to the development of secondary tumors, local recurrence, and regional failure. Invasive treatments frequently have a negative impact on the aesthetic and functional outcomes of survivors. Novel approaches are thus needed to manage this deadly disease in light of these statistics. In photodynamic therapy (PDT), a light-sensitive medication called a photosensitizer is given first, followed by exposure to light of the proper wavelength that matches the absorbance band of the photosensitizer. The tissue oxygen-induced cytotoxic free radicals kill tumor cells directly, harm the microvascular structure, and cause inflammatory reactions at the targeted sites. In the case of early lesions, PDT can be used as a stand-alone therapy, and in the case of advanced lesions, it can be used as adjuvant therapy. The current review article discussed the uses of PDT in oral cancer therapy based on recent advances in this field.

Indexed as

Mouth NeoplasmsPhotochemotherapyCombined Modality TherapyHumansPhotosensitizing AgentsPhotosensitizing AgentsCancerOralOSCCPhotodynamic

Identifiers

PMID36749489
OpenAlexW4319334225

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.